SutroVax

SutroVax

SutroVax

SutroVax is dedicated to delivering best-in-class conjugate vaccines & complex antigen-based vaccines to prevent deadly infectious diseases.
Suggest edits
Type
B2b
Founded
2013
Raised
$277M
Follow us
Also headquartered in San Francisco
Companies in the same industry
Alexa global traffic share
Terms of Service Privacy Policy Cookie Statement API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2020
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 4

Add info
Latest funding Show all
$85,000,000
Venture capital (Series C) - 2018
Foresite Capital TPG Growth Abingworth +6
Team Size
2
Employees
I work here
Location
San Francisco ,  United States
Headquarters
Explore San Francisco
$110,000,000 Venture capital (Series D)
FinSMEs

SutroVax Raises $110M in Series D Financing

SutroVax
SutroVax
$85,000,000 Venture capital (Series C)
PE HUB , FinSMEs

SutroVax reels in $85 mln Series C

Messaging
SutroVax
SutroVax
Xconomy

SutroVax Lands $64M From Roche, Others to Back Vaccine Studies

Health Funding
Roche
Roche
SutroVax
SutroVax
$22,000,000 Venture capital (Series A)
Xconomy

With $22M Shot of Venture, Sutro Spinout Aims For Better Vaccines

Health
SutroVax
SutroVax